Acquiring Company
Fertifa
Acquired Company
Tuune
StrandHealth CareDescription
Fertifa has agreed to acquire women's health technology company Tuune, extending its employee healthcare services into personalised hormonal care. Tuune's regulated clinical software assesses more than 70 symptoms to support contraception and menopause decisions. The deal follows Fertifa's purchase of reproductive health insurer Juniper last year. The transaction is described as proposed, so it has not yet closed.
Who to call at Fertifa, and when
When Fertifa changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Fertifa raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Fertifa, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Fertifa. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Fertifa makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Tuune?
Tuune was acquired by Fertifa, based in Strand. The deal was reported on November 6, 2026. We're the UK and Europe's leading reproductive benefits provider 🌍 Reproductive health is something that impacts so many of us. We created Fertifa to give people the help and support they need, whenever they need it. Fertifa is privately held and operates in Health Care.
When did Fertifa acquire Tuune?
Fertifa's acquisition of Tuune was reported on November 6, 2026. Fertifa has agreed to acquire women's health technology company Tuune, extending its employee healthcare services into personalised hormonal care. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Tuune do?
Tuune is a personalized women’s healthcare company, re-inventing the way healthcare accesses the complexity of female hormones with a focus on individuality. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.